PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Symptom | C0239946|liver fibrosis |
| Sentences | 4 |
| PubMedID- 23107811 | Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. |
| PubMedID- 26269292 | Objectives: a concern about methotrexate (mtx)-related liver fibrosis in patients with rheumatoid arthritis (ra) is still unresolved. |
| PubMedID- 26361561 | The purpose of this study was to evaluate the usefulness of mre in detecting and quantifying liver fibrosis in patients with rheumatoid arthritis (ra) who have received methotrexate (mtx). |
| PubMedID- 19854710 | Objective: to evaluate the impact of tumour necrosis factor alpha (tnfalpha) blockers on the presence of liver fibrosis in patients with rheumatoid arthritis (ra) and psoriatic arthritis (psa) treated with methotrexate (mtx). |
Page: 1